Glaxo Wellcome # 131-002 A Phase I/II trial to evaluate the safety, pharmacokinetics and preliminary effects of multiple dosing of 1592U89, alone and in combination with Retrovir capsules upon selected immunologic and virologic markers of HIV infection.
Showing the most recent 10 out of 1065 publications